Clifton Promise’s B blood sample to be tested soon

Jonathan Paget walking the Greenwich cross-country course of report at the Olympic Games inward London terminal year. © Mike Bain

The B sample of blood taken from Jonathan “Jock” Paget’s mount, Clifton Promise, volition undergo analysis inward mid-November.

The H5N1 sample taken from the Equus caballus equally business office of routine testing later his victory at the Burghley International Horse Trials tested positive for the long-acting sedative, reserpine.

Resperine is listed on the FEI’s Clean Sport database equally a prohibited substance. It is classed equally a tranquiliser, in addition to is an alkaloid used for long-term sedation inward horses.

Equestrian Sports New Zealand (ESNZ) said today that it had received notification from the FEI that the analysis of the B sample would laissez passer on off inward mid-November, amongst the results notified to the New Zealand torso in addition to the passenger inward due course.

The timescale was a normal business office of the legal procedure currently nether way, ESNZ said inward a brief statement. “You volition appreciate that neither Jock nor ESNZ tin brand farther comment at this stage.”

Paget remains provisionally suspended from whatever national or international contest in addition to Clifton Promise is serving a provisional two-month suspension, pending the B sample in addition to whatever subsequent hearings.

When word of the positive H5N1 sample broke inward mid-October, Paget expressed his daze at the reserpine finding, proverb he could non sympathize how the drug came to move inward the horse’s system.

Clifton Eventers, who supplies Paget amongst his mounts, has voiced its back upward for Paget in addition to is supporting him inward grooming for an FEI disciplinary judicature hearing, should the B sample testify positive for the drug.

 

Bagikan Artikel ini